Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 137.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.00
  • 52 Week Low: 102.50
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 11,653
  • Market Cap: 146.07m
  • RiskGrade: 129
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 146.43 13.10 9.29p 14.8 4.9 +3% 2.67p 1.9%
31-Dec-20 171.41 14.10 9.62p 14.3 4.0 +4% 4.16p 3.0%
31-Dec-21 176.34 15.00 10.25p 13.4 2.0 +6% 4.47p 3.2%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2020 171 181 n/a n/a n/a n/a
31-Dec-2021 176 187 n/a n/a n/a n/a
 
Earnings
31-Dec-2020 9.62p 10.34p n/a n/a n/a n/a
31-Dec-2021 10.25p 10.88p n/a n/a n/a n/a
 
Dividend
31-Dec-2020 4.16p 4.46p n/a n/a n/a n/a
31-Dec-2021 4.47p 4.74p n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 0 1 1 1 1
Buy 0 0 0 0 0 0
Neutral 1 1 1 1 1 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 1 2 2 2 2
 
Average Rec 7.50 5.00 7.50 7.50 7.50 7.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 137.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.00
52 Week Low 102.50
Volume 11,653
Shares Issued 106.23m
Market Cap 146.07m
RiskGrade 129

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.92% below the market average57.92% below the market average57.92% below the market average57.92% below the market average57.92% below the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Trend
60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Income
20.32% above the market average20.32% above the market average20.32% above the market average20.32% above the market average20.32% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
30.69% below the market average30.69% below the market average30.69% below the market average30.69% below the market average30.69% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 24-Jan-2020

Time Volume / Share Price
16:25 400 @ 138.60p
14:59 4,000 @ 136.50p
14:10 13 @ 138.60p
11:03 760 @ 136.16p
09:33 6,480 @ 138.60p

Cello Health Key Personnel

CEO Mark Scott

Top of Page